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Abstract
The cloned canine betaine-GABA cotransporter BGT-1 has been heterologously expressed in Xenopus laevis oocytes in
order to characterize its electrophysiological properties. Voltage-clamp experiments on transfected oocytes reveal the
presence of three types of membrane current which are absent in non-injected oocytes: (i) an organic substrate-independent
current (uncoupled current); (ii) a transport-associated current, seen upon addition of betaine or GABA; (iii) presteady-state
currents induced by voltage changes. The three kinds of current are analogous to those reported in structurally similar
cotransporters. The transport-associated current is strictly dependent on the presence of Na. The good correlation between
the amount of charge underlying the presteady-state currents and the transport-associated current indicates that both
processes are due to the activity of the transporter. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Amino acid cotransporters are involved in several
physiological processes: they allow cells to take up
nutrients as glucose and amino acid, to adapt to
alteration in osmolarity and, in the nervous system,
help to terminate the synaptic transmission by re-
moving the neurotransmitter from the synaptic cleft.
The application of molecular biology techniques has,
in the last years, allowed the cloning of a number of
molecules responsible for the transmembrane trans-
port of these important elements. Many transporters
have in common a dependence on sodium and chlo-
rine ions and a similar 12-transmembrane segment
topology. In the family of Na/Cl3 transporters,
the GABA transporters are considered the prototype
[1]. From the ¢rst GABA transporter [2] various
other GABA uptake systems have been cloned [3^
6]. These transporters have been identi¢ed not only
in di¡erent brain areas and cellular types but they
have also been found widely expressed outside the
nervous system [6,7].
We focused our attention on one of these trans-
porters: BGT-1 (betaine-GABA transporter) that has
been only recently characterized for its functionality
[8]. BGT-1, the fourth GABA transporter, was iden-
ti¢ed in renal physiology studies; it was ¢rst cloned
from Madin Darbin canine kidney (MDCK) cells [7].
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This cotransporter is encoded by a cDNA of 1844
bp, that predicts for a protein of 614 amino acids
with a molecular mass of 69 kDa that has high iden-
tity with the human brain hBGT-1 (91%) the rat
GAT-2 (70%) and GAT-3 (66%), and the mouse
GAT-2 (87%) transporters. Hydrophobicity analysis
indicates the presence of 12 transmembrane domains
with two potential glycosylation sites in the extracel-
lular loop between segments 3 and 4. BGT-1 is able
to transport GABA and betaine as substrates.
BGT-1 has greater a⁄nity (Km = 19 WM) for
GABA than for betaine (Km = 600 WM) (at 350
mV) [8]; this is in agreement with the di¡erent con-
centration of these two substrates in plasma: that of
betaine is about 180 WM, while the concentration of
GABA is less than 1 WM. In the kidney the function
of this transporter is that of accumulating the osmo-
lyte glycine betaine (betaine) in response to hyper-
tonic conditions in the medulla, but its widespread
di¡usion and its high a⁄nity for GABA have at-
tracted interest to better understand the signi¢cance
of GABA uptake outside the nervous system.
Electrophysiological measurements on Xenopus
oocytes that may be induced to express BGT-1 at
high density can help to better de¢ne its character-
istics with regard to ion binding, voltage dependence
and permeation properties.
2. Materials and methods
2.1. Preparation of mRNA and oocyte injection
The cDNA encoding the betaine transporter
cloned into the pSPORT1 vector was kindly pro-
vided by J.S. Handler (Johns Hopkins University)
[7]. Capped cRNA speci¢c for BGT-1 was synthe-
sized in vitro using a NotI cleaved pSPORT-BGT-1
cDNA construct with T7 RNA polymerase.
Oocytes were prepared as previously described [9] ;
brie£y, portions of ovary were removed through a
small incision on the abdomen from Xenopus laevis
frogs anaesthetized in MS222 (tricaine methane-
sulphonate) 0.15% (w/v) solution in tap water. The
oocytes were then treated with collagenase (Sigma
Type IA) 1 mg/ml in ND96 Ca2 free solution
(NaCl, 96; KCl, 2; MgCl2, 1; HEPES, 5; all values
in mM, pH 7.6), for at least 1 h at 18‡C. A manual
microinjection system (Drummond, Broomall, PA,
USA) was used to inject 50 nl of water containing
12.5 ng of BGT-1 coding cRNA per oocyte. Non-
injected oocytes were used as control.
The oocytes were incubated at 18‡C for 2^3 days
in NDE solution (NaCl, 96; KCl, 2; CaCl2, 1.8;
MgCl2, 1; HEPES, 5; all values in mM, pH 7.6),
supplemented with 50 Wg/ml gentamicin and 2.5
mM Na pyruvate), before electrophysiological ex-
periments.
2.2. Electrophysiology
The two-microelectrode voltage-clamp technique
(GeneClamp, Axon, Foster City, CA, USA) was
used to control the potential and measure the mem-
brane currents of isolated oocytes. Experimental pro-
tocols and data acquisition and analysis were done
using the pClamp 8 software (Axon). Longer lasting
records, such as those in Figs. 1 and 2, were ¢ltered
at 20 Hz and sampled at 50 Hz, while currents in
response to brief pulses (as in Fig. 3) were ¢ltered at
1 kHz and sampled at 2 kHz; averaging of four
traces was normally performed in these experiments.
Estimate of the amount of charge movement from
the current transients was performed as explained in
detail in Section 3.5. Exponential ¢tting was per-
formed using the Simplex or Chebyshev method of
the Clamp¢t 8 analysis software (Axon).
2.3. Solutions
The compositions of the external solutions used in
the present experiments are summarized in Table 1.
Table 1
Composition of solutions
High
Na
High
K
High
Li
TMA
NaCl 98 ^ ^ ^
KCl ^ 98 ^ ^
LiCl ^ ^ 98 ^
TMACl ^ ^ ^ 98
MgCl2 1 1 1 1
CaCl2 1.8 1.8 1.8 1.8
HEPES free acid 5 5 5 5
The pH was adjusted to 7.6 by adding the corresponding hy-
droxide for each alkali cation and TMAOH for the TMA so-
lution.
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GABA or betaine was added at the indicated con-
centrations to the various solutions. These were
superfused by gravity onto the oocyte by a pipette
tip placed very close (1^2 mm) to the cell.
3. Results
Non-injected Xenopus oocytes exhibit only small
changes in membrane current when challenged with
betaine or GABA (100 WM) under voltage-clamp
conditions (Vh =380 mV) in high Na solution; as
shown in Fig. 1A, addition of betaine and GABA
actually causes a small reduction of the holding cur-
rent. On the contrary, oocytes injected with the
cRNA coding for the canine renal isoform of BGT-
1 respond with a de¢nite increase in inward current
when stimulated in the same way (Fig. 1B), as al-
ready reported [8].
While the reason of the current reduction in con-
trol oocytes is not known, the currents induced by
the two substrates in the same oocyte clearly indicate
that a protein with the properties expected for a be-
taine-GABA transporter is present in the membrane.
The current time courses are similar to those ob-
served in other amino acid cotransporters [9,10],
while their amplitude is rather small.
The relatively small currents observed in Fig. 1B
are anyway su⁄cient to signi¢cantly displace the
membrane potential of the oocyte in current clamp;
this is shown in the experiment of Fig. 1C,D: an
injected oocyte was ¢rst kept in voltage-clamp con-
ditions and stimulated with 100 WM GABA, which
elicited a current increase of about 8 nA (Fig. 1B);
the voltage clamp was then turned o¡ and the same
oocyte was stimulated again under current-clamp
conditions (Fig. 1D); it can be seen that application
of GABA in this case produced a depolarization of
almost 20 mV.
3.1. Ionic speci¢city
For another transporter of the Na/Cl3-dependent
family, KAAT1, we have recently reported the cou-
pling of the transport process to K and Li [11,12];
we have therefore checked the ionic selectivity of the
Fig. 1. Electrophysiological e¡ects induced by addition of betaine and GABA. Recordings from a non-injected oocyte (A), and from
an oocyte injected with BGT-1 cRNA (B) in Na solution. Holding potential 380 mV. Oocytes from the same batch. (C,D) Voltage-
clamp and current-clamp responses (respectively) induced by GABA in the same oocyte. Vh =380 mV. Perfusions of organic sub-
strates are indicated by the black bars.
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BGT-1 transporter by performing experiments using,
in addition to Na, also TMA, K and Li as
possible coupling ions. Fig. 2 shows the results of
typical experiments of this kind from which it is ap-
parent that both organic substrates require the pres-
ence of Na to induce an inward current in BGT-1-
injected oocytes. Negligible changes are induced by
addition of either substrate when TMA is the main
external bathing ion and a small inward current oc-
curs in the presence of K upon addition of GABA;
however, a current of similar amplitude and time
course can also be observed when GABA is added
in K-bathed control oocytes (Fig. 2A), indicating
that this current is caused by endogenous compo-
nents of the oocytes. No current changes could be
observed in Li (not shown).
3.2. Uncoupled current
Several neurotransmitter cotransporters that share
structural similarity with BGT-1 have the ability of
transporting ions in the absence of substrate
[9,13,14]. We have investigated whether BGT-1 also
possesses this property by comparing the increase in
inward current that occurs when the external solu-
tion is changed from TMA, an ion that is imper-
meant in most channels and in the cotransporter
KAAT1 [9], to Na. Examples of such changes can
be seen in Figs. 1C,D and 2, where it is apparent that
the current change in BGT-1-expressing oocytes is
larger than in non-injected ones.
At Vh =380 mV, the average INa3ITMA in non-
injected oocytes amounts to 32.57 þ 0.57 nA (S.E.,
n = 12), and in injected oocytes to 36.30 þ 0.56 nA
(S.E., n = 19), the two values being signi¢cantly dif-
ferent at the 0.001 level. This result may suggest the
presence of the uncoupled mode of ion transport also
for BGT-1, although caution is mandatory on this
¢nding given the very small currents.
3.3. Voltage dependence of the cotransporter-related
currents
To study the voltage dependence of the currents
Fig. 2. Na speci¢city of the substrate-induced current. Injected and control oocytes were stimulated with GABA and betaine in the
presence of either TMA, Na or K as principal external ion. The large de£ections upon changing to the K solution are due to
the endogenous K channels of the oocytes. Perfusions of organic substrates are indicated by the black bars.
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observed above, we have used a voltage-clamp pro-
tocol consisting of 100 ms long square pulses from
Vh =340 mV and covering the range from 3140 to
+40 mV. Sample current traces from a non-injected
and an injected oocyte in TMA, Na and Na+100
WM GABA are shown in Fig. 3. Compared to con-
trols, injected oocytes tended to have larger steady-
state currents even in TMA, possibly suggesting
that also TMA could permeate the transporter in
an uncoupled mode.
In addition to the already mentioned uncoupled
and transport-associated currents, in injected oocytes
the traces show relatively large ‘presteady-state’ cur-
rents elicited by the voltage jumps; di¡erently from
controls, in which only fast capacitative transients
can be seen at the ‘on’ and ‘o¡’ of the voltage pulse,
in the injected oocytes large and much slower current
relaxations are observed when the oocyte is bathed in
Na (Fig. 3, middle panel, right column). These re-
laxations are alike those observed in several other
cotransporters [9,15,16] and similarly are reduced
when the organic substrate is added (right column,
bottom panel) or when Na is replaced by TMA
(right column, top panel).
In Fig. 4 the average steady-state I-V curves ob-
tained in several conditions from a group of injected
oocytes are shown; the transport-associated current
increases with hyperpolarization and is S-shaped. In-
terestingly, no reversal can be observed in Fig. 4B at
Fig. 3. Presteady-state currents. Voltage-clamp pulses, 100 ms
long from 3140 to +40 mV, in 40 mV increments (Vh =340
mV), were applied to a control and to an injected oocyte
bathed in the indicated solutions.
Fig. 4. Voltage dependence of the uncoupled and transport-as-
sociated currents. (A) Average steady-state I-V curves from in-
jected oocytes bathed in TMA (squares), Na (circles) and
Na+100 WM GABA (triangles) ( þ S.E., n = 7). (B) Transport-
associated current (i.e. di¡erence between triangles and circles).
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positive potentials : this behaviour is similar to that
observed in the KAAT1 transporter [9,17] and prob-
ably re£ects the fact that in these conditions the driv-
ing force for the transport is supplied by the concen-
tration gradient of the organic substrate. The I-V
curve in TMA and Na in Fig. 4A are signi¢cantly
di¡erent, con¢rming the indication for an uncoupled
current.
3.4. Presteady-state currents
The current traces like those of Fig. 3 were ¢tted
with exponential functions to determine the time
constants (d) of the relaxations. A single exponential
was su⁄cient to adequately describe the capacitative
transients of non-injected oocytes, both in Na and
TMA bathing medium: as shown in Fig. 5A (¢lled
symbols), in this case d had a value of about 1 ms
and was voltage-independent. In oocytes expressing
BGT-1 a double exponential function was necessary.
The slower time constant depended on the composi-
tion of the bathing solution, being larger and volt-
age-dependent in the presence of Na, and reduced
in the presence of TMA or when GABA was added
to Na (Fig. 5B). The faster time constant was volt-
age-independent with a value close to that of non-
injected oocytes in all conditions (Fig. 5A, open sym-
bols). All the above observations suggest that the fast
transient component represents the charging of the
oocyte membrane capacity, while the slower compo-
nent is related to the di¡erent states of the transport-
er.
The fact that in the presence of GABA or when
Na is substituted by TMA ¢tting of the transients
still requires the sum of two exponentials indicates
that some charge movement may still occur in these
conditions, di¡erently from the ¢ndings from other
transporters of the same family [9] (see Section 4).
3.5. Charge movement analysis
In order to estimate the amount of charge moving
in the membrane electrical ¢eld following voltage
jumps, the transient currents must be isolated from
the passive capacitative currents of the oocyte mem-
brane. The ¢ndings of Fig. 5 justify the procedure,
already used by other authors [16,18], of peeling o¡
Fig. 5. Time constants of the current relaxations. Exponential
functions were ¢tted to traces like those in Fig. 3. In A, ¢lled
symbols represent values from single exponential ¢tting in con-
trol oocytes (mean þ S.E., n = 6), while open symbols represent
the fast component of a double exponential ¢tting in injected
oocytes (mean þ S.E., n = 7). In B, open symbols represent the
corresponding slow component in injected oocytes.
Fig. 6. Analysis of presteady-state currents. Average Q vs. V
curves for injected oocytes (mean þ S.E., n = 7) in Na without
(squares) or with (circles) 100 WM GABA, and in TMA (trian-
gles). Fitting the squares with a Boltzmann equation gave the
following parameters: Qmax = 4.83 þ 0.15 nC, V1=2 =316.7 þ 1.6
mV and slope factor s = 28.7 þ 1.3 mV.
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the fast exponential component leaving the slow one
as representing the isolated presteady-state currents.
These traces were then integrated after subtraction
of the steady-state level to give the amount of charge
moved at each potential. The resulting Q-V curves
for the various conditions are plotted in Fig. 6.
The curve in Na (without GABA) is typically S-
shaped, as expected for intramembrane charge move-
ment, and can be ¢tted by a Boltzmann relationship
giving the parameters reported in the legend of Fig.
6. However, integration of the slow components of
the traces obtained with TMA substitution of Na,
or in Na with GABA, indicates that some charge
movement is still present in these conditions.
3.6. Relation between presteady-state and
transport-associated currents
The presteady-state currents observed in many co-
transporters are believed to represent the in and out
movements of Na binding to a site located inside
the membrane electrical ¢eld and/or a charge-moving
conformational change of the transporter protein as-
sociated with one or more partial reactions during
the transport cycles [9,19]. This implies that there
should be a proportionality between the amount of
the measured presteady-state charge and the number
of expressed cotransporters and, consequently, the
amplitude of the transport-associated current. Fig.
7 plots this relation as obtained in our experiments
from a group of seven oocytes.
The two quantities appear to be linearly related, as
suggested by a correlation coe⁄cient of 0.93, indicat-
ing that both presteady-state charge movement and
transport-associated currents are likely to be gener-
ated by the transporter.
4. Discussion
The betaine-GABA transporter BGT-1, cloned
from MDCK cells, shares structural homology with
the family of Na/Cl3-dependent amino acid co-
transporters [7]. Its recent expression in Xenopus oo-
cytes has revealed that it is able to generate trans-
port-associated membrane currents whose
characteristics are in agreement with the results of
uptake experiments [8]. In the present work we
have analysed in greater detail the electrophysiolog-
ical properties of BGT-1.
4.1. Uncoupled current
The ¢rst new ¢nding in our work is the presence of
uncoupled currents in BGT-1. As mentioned above,
this result should be taken with caution since, though
statistically signi¢cant, the e¡ect is very small. Sev-
eral Na-coupled cotransporters exhibit this feature
[13,20,21] although, with the possible exception of
the lepidopteran amino acid transporter KAAT1
[9], no clear physiological meaning for this current
has been proposed. Considering that BGT-1 is in-
volved in volume regulation and that its expression
is stimulated by hypertonicity [7,22,23], it may be
hypothesized that an uncoupled Na £ux through
it may contribute, in addition to the £ux of other
osmolytes, to the processes involved in volume recov-
ery.
4.2. Presteady-state current
A second characteristic feature of many cotrans-
porters is also present in BGT-1: i.e. the presence of
voltage-dependent intramembrane charge movements
[13,15]. These are believed to arise from partial reac-
tions in the transporter cycle, either from the back
and forth motion of sodium ions between the extra-
cellular solution and a binding site located inside the
membrane electrical ¢eld, or to a charge-displacing
Fig. 7. Relationship between the amount of transport-associated
current (measured at 3140 mV and Qmax for seven oocytes).
The solid line represents the linear regression through the
points.
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conformational change of the transporter molecule,
or to both processes [11,13,24].
The parameters obtained by ¢tting a Boltzmann
equation to the Q vs. V curve of Fig. 6 are very
similar to those obtained by Mager et al. [15] for
GAT-1. From these parameters it is possible to esti-
mate the number of transporter molecules expressed
in each oocyte from the relation: N = QmaxWs/kT
[9,20] which turns out to be of the order of 1010 in
our experiments.
A di¡erence in the characteristics of the presteady-
state currents of BGT-1 with respect to those previ-
ously described in other transporters is the persis-
tence of a residual fraction of charge movement
when the organic substrate is added, and also in
zero external Na (Figs. 3,5 and 6). This observation
may indicate in BGT-1 the presence of a second kind
of charge rearrangement, in addition to that related
to the binding of Na to the transporter and/or a
small contribution of TMA to the charge move-
ment. In connection to this, a recent report [18] has
shown the existence in a phosphate cotransporter of
a component of presteady-state currents in the ab-
sence of external Na.
In BGT-1 there is a lack of correspondence be-
tween the half-charge voltage and the voltage at
which d is maximal (Figs. 5B and 6), which is signi¢-
cantly more negative. This implies that the rate con-
stant for the outward movement of the charge is
more voltage-dependent than the inward rate con-
stant, and represents another di¡erence with respect
to GAT-1 [20].
4.3. Relation between transport-associated current and
Qmax
As shown in Fig. 7, the relationship between trans-
port-associated current and the value of Qmax is lin-
ear. This result supports the idea that both processes
are related to the same entity, i.e. the cotransporter.
At 3140 mV the slope of this relationship is 21.7
s31 ; in the interpretation that the presteady-state
current is due to charges resting in a site during
the permeation process, this value may be interpreted
as the turnover rate of the transporter and it is
worthwhile noting that the above value is similar to
the rate determined for GAT-1 [15].
In conclusion, the electrophysiological properties
of BGT-1 appear to substantially conform to those
of the Na/Cl3-dependent family of cotransporters
and more generally to those of the 12-transmem-
brane segment amino acid cotransporters.
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